Abzena

Abzena is a leading end-to-end CDMO and CRO for complex biologics, bioconjugates (ADCs, AOCs, RDCs) and bispecifics, supporting customers from early-stage discovery through commercial manufacturing with fully integrated programs or individual services designed to de-risk and streamline new medicine development. With over two decades of experience, more than 2,000 conjugates developed and over 200 cell lines developed, Abzena operates facilities in Cambridge, UK, San Diego, California and Bristol, Pennsylvania.